CGNSF (CGNSF) Stock Price & Analysis
CGNSF (CGNSF) rose 0.00% to USD 0 as of June 10, 2026 at 05:04 UTC, according to Nexqual real-time market data.
CGNSF last closed at USD 0; the session ranged USD 0–0 on volume of 1,000 shares. Market capitalization is $8,958, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 05:04 UTC.
Key Statistics (as of June 10, 2026 at 05:04 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 1,000 shares |
| Market Cap | $8,958 |
| Exchange | PNK |
Technical Analysis (CGNSF)
Nexqual's technical model rates CGNSF "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 05:04 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (CGNSF)
Wall Street analysts rate CGNSF "None", per Nexqual as of June 10, 2026 at 05:04 UTC.
| Consensus Rating | None |
|---|
Earnings (CGNSF)
Source: Nexqual, June 10, 2026 at 05:04 UTC.
Financials & Fundamentals (CGNSF)
| Total Revenue | $98,971 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | -3033.40% |
| Profit Margin | +0.00% |
| Current Ratio | 0.04 |
| Total Cash | $16,570 |
| Total Debt | $1.37M |
| Free Cash Flow | $-2.21M |
Source: Nexqual, June 10, 2026 at 05:04 UTC.
Financial Health Score (CGNSF)
Nexqual rates CGNSF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:04 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $17K cash vs $1M debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Mixed — No data |
Ownership (CGNSF)
| Insider Ownership | +13.50% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 89.59M |
| Float | 82.22M |
Source: Nexqual, June 10, 2026 at 05:04 UTC.
Leadership (CGNSF)
CGNSF is led by Sina Habibi, Co-Founder, CEO & Director, per Nexqual as of June 10, 2026 at 05:04 UTC.
| Co-Founder, CEO & Director | Sina Habibi |
|---|---|
| CFO, Company Secretary & Director | Thomas Roger Sawyer (age 55) |
| Legal Counsel & Director | Desmond M. Balakrishnan B.A., L.L.B. (age 54) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IZOZF | Izotropic Corporation | USD 0.2 | ▼ 0.99% |
| DUSYF | DUESENBERG TECHNOLOGIES INC | USD 0 | ▲ 0% |
| TOBAF | TAAT Global Alternatives Inc. | USD 0.01 | ▲ 0% |
| CLCFF | Christina Lake Cannabis Corp. | USD 0.02 | ▼ 16% |
| MVVYF | Moovly Media Inc | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:04 UTC. This page is informational and not investment advice.